EU OK for paediatric trials in haematology and neurology
This article was originally published in Scrip
Executive Summary
The EMEA's paediatric committee has given the go-ahead to more plans for drug trials in children, although it turned down proposed trial programmes for two combination drug products and instead issued a full waiver.